Table 1.
Inclusion | Exclusion |
---|---|
Oral cavity, oropharynx, hypopharynx, larynx and/or nasopharynx carcinoma | Inclusion of patients <1,990 |
T2–4 squamous cell carcinoma | Population ≤10 |
Treatment with chemoradiotherapy | Treatment with surgery or radiotherapy alone |
Outcome measurements of speech and/or Voice | Outcomes solely about survival, nutrition or toxic effects |